Comparative teratogenicity of triamcinolone acetonide, triamcinolone, and cortisol in the rat

Jon M. Rowland, Andrew G Hendrickx

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Pregnant rats were injected im with 0.5 mg/kg triamcinolone acetonide (TAC) on day 12, 13, or 14 of gestation and the fetuses were examined for cleft palate on day 20. All three TAC‐treated groups showed an increased proportion of fetuses with cleft palate compared to an untreated control group. Only the group treated on day 13 showed a significant increase in the proportion of litters affected. This indicates that day 13 of gestation is the most sensitive day for cleft palate induction by TAC in the rat. Pregnant rats were then treated on day 13 of gestation with either TAC, triamcinolone (TA), or cortisol. TAC was 59 times as potent as TA in inducing cleft palate, with ED50 values of 1.1 mg/kg and 65 mg/kg respectively. Cortisol induced a significant increase in cleft palates at 500 mg/kg, but the efficacy of this compound was too low to calculate an ED50 and relative teratogenic potency value. Other developmental abnormalities including umbilical hernias, resorption, and fetal death resulted from TAC treatment. Fetal growth retardation was produced by all three compounds. The rank order of teratogenic potency was determined to be TAC > TA > cortisol.

Original languageEnglish (US)
Pages (from-to)313-319
Number of pages7
JournalTeratogenesis, Carcinogenesis, and Mutagenesis
Issue number4
StatePublished - 1983


  • cleft palate
  • corticosteroids
  • cortisol
  • growth retardation
  • teratogenic potency in rats
  • triamcinolone
  • triamcinolone acetonide
  • umbilical hernias

ASJC Scopus subject areas

  • Oncology
  • Toxicology
  • Genetics
  • Genetics(clinical)
  • Health, Toxicology and Mutagenesis


Dive into the research topics of 'Comparative teratogenicity of triamcinolone acetonide, triamcinolone, and cortisol in the rat'. Together they form a unique fingerprint.

Cite this